Blog

Teams building covered stents, shunts, flow diverters, LAA devices, heart pumps, or embolic protection systems already juggle materials, mechanics, deliverability, regulatory strategy, and funding. In that complexity, early biological considerations, especially at the interface between tissue and the device covering, often get less attention. That interface, however, is not a minor detail. It is a dynamic, microscopic environment where blood, vessel or atrial tissue, and the

Covered scaffolds have long promised the best of both worlds: mechanical support combined with controlled biological interaction. Yet despite decades of innovation, several core challenges continue to limit their performance and long-term outcomes. Understanding these barriers is critical for advancing next-generation vascular implants. 1. Persistent Thrombosis Risk One of the most stubborn issues with covered scaffolds is their inherent thrombogenicity. Unlike bare-metal or

The evolution of endovascular therapy is a story of continuous refinement in both device mechanics and material interfaces. In covered stents and stent grafts, early innovation focused mainly on macro-scale performance such as deliverability, radial strength, and fatigue resistance, but attention has increasingly shifted toward the microscopic interface between the polymer membrane and the metallic scaffold as a determinant of long‑term clinical outcomes. Expanded polytetrafl

The Challenge: Overcoming Mechanical Resistance An OEM partner was developing a next-generation covered device intended for a highly tortuous vascular pathway. Their prototype was hitting a "flexibility ceiling." The traditional "sandwich" construction of the membrane was making the device too stiff to navigate tight anatomical bends without significant force, raising concerns about vessel "biasing" (straightening) and potential trackability failure. The Medibrane Solution: E

Q: Why do covered stents still struggle with deliverability compared to bare‑metal stents? Because coverage traditionally comes at a mechanical cost. Bare‑metal stents are essentially flexible scaffolds. Once a polymer membrane is added, wall thickness increases, stiffness rises, and the stent begins to behave less like a conformable structure and more like a rigid tube. In tortuous or calcified anatomy, that difference is immediately felt by the physician during delivery. Th

In endovascular engineering, tradeoffs are often treated as immutable laws. One of the most persistent is the assumption that clinicians must choose between the structural benefits of a covered stent and the effortless navigation of a bare‑metal one. In practice, this compromise shows up in the interventional suite every day. When physicians navigate tortuous anatomy,tight S‑curves in dialysis access circuits or heavily calcified peripheral arteries, trackability is everythin

In covered stents and other scaffold‑based implants, device performance is often dictated by a single, easily overlooked detail: how the cover is attached to the scaffold. The interface between fabric or membrane and metal must withstand crimping, delivery, expansion, and long‑term cyclic loading, while maintaining a low profile, predictable mechanics, and reliable sealing. Traditionally, this interface has been addressed using mechanical or thermal workarounds such as sewing

When manufacturing advanced neurovascular or cardiovascular devices,such as embolic protection devices and drug delivery catheters,the quality of the polymer covering on the Nitinol scaffold can make or break the product. Covering these intricate, shape-memory structures requires precision, reliability, and ultra-low profiles. For years, manufacturers have relied on traditional methods like dip coating, manual gluing, or soldering to attach Thermoplastic Polyurethane (TPU) me

Medical devices are evolving rapidly. Today’s stent grafts are rarely just simple, straight tubes; they feature flares, branches, tapers, and highly intricate, patient-specific geometries. When it comes to covering these complex scaffolds with expanded polytetrafluoroethylene (ePTFE), traditional manufacturing methods are hitting a wall. Historically, encapsulating ePTFE onto a stent by sintering has been the standard. But when applied to complex shapes, sintering forces engi

For decades, expanded polytetrafluoroethylene (ePTFE) has been the gold standard for covering stents. Its biocompatibility and durability make it ideal for treating aneurysms, fistulas, and other vascular conditions. However, the method  used to attach the ePTFE to the bare metal stent plays a critical role in the device's clinical success. Historically, manufacturers have relied on sintering and encapsulation to secure the polymer to the metal struts. But as endovascular pro

In today’s cardiovascular , structural heart and neurovascular device landscape, innovation doesn’t stop with the stent or frame , it depends on how the cover  performs in the body. Medibrane partners with medical device innovators to solve the persistent biological and mechanical challenges that limit covered stents, occluders, and flow‑modulating devices. The Clinical Challenge: Healing vs. Hemodynamics A polymer cover can protect, seal, or control blood flow, yet it can al

When designing covered stents, we typically focus on the usual levers: base material, ePTFE microstructure, and wall thickness. One design parameter that often receives less attention—but can significantly influence vascular healing and neointimal hyperplasia—is how effectively the cover is mechanically coupled to the stent struts. In practical terms:Well‑adhered covers support more stable healing, while poorly adhered covers can promote chronic inflammation and excessive tis

1.     Why does the design of a stent cover layer matter for tissue growth? Because the cover layer is the primary biological interface between the device and the body. Its microstructure strongly influences how blood proteins, platelets, inflammatory cells, and tissue interact with the implant. Small changes in pore size, porosity, or surface chemistry can meaningfully affect healing, thrombosis risk, restenosis, and long‑term device performance. 2.     What is meant by “int

In many medical devices, the way two materials meet and stay bonded is just as important as the design of the device itself. When metals, polymers, textiles, and coatings connect, their interface determines how the device performs, how long it lasts, and how safe it is inside the body. Covered Stents and Scaffolds Covered stents must combine the strength of a metal scaffold with the flexibility of a thin covering. That covering has to stay attached while the device bends, exp

Bonding Microelectronics components  to Balloons, Stents, and Catheters Integrating electrodes, sensors, and PCB assemblies onto balloons, stents, and catheter shafts is a major engineering challenge. These components must remain securely attached while the device bends, expands, compresses, and moves through tortuous anatomy. Traditional bonding techniques struggle to meet these requirements.   The Problem with Conventional Methods Most manufacturers still rely on manual adh

1. What does Medibrane specialize in? Medibrane designs and manufactures advanced polymeric covers, membranes, and microlayer tubing  for minimally invasive medical devices, particularly for stents, catheters, vascular implants, neurovascular devices, and GI devices . The company integrates material science with engineering to deliver ultra‑thin coverings, selective bonding, and sutureless lamination solutions. 2. What problems does Medibrane help medical device companies sol

1. What are graft materials in cardiovascular implants? Graft materials are biocompatible fabrics or membranes  used to cover or reinforce structural medical devices such as stents, occluders, and heart valves. Their purpose is to provide a blood-tight barrier , promote tissue ingrowth , and reduce complications like leakage or thrombosis. 2. Why are stents sometimes covered with graft materials? Covered stents are used when physicians need to seal a tear, close a fistula, or

1. What is Dacron and why is it used for stent coverings? Dacron (polyester) is known for its strength, durability, and biocompatibility. It's commonly utilized in vascular grafts and stent coverings due to its excellent sealing properties and ability to promote tissue ingrowth. 2. What are the benefits of using Dacron fabric on stents? Offers high mechanical strength and resistance to tearing. Its porosity encourages tissue integration, minimizing migration risks. Demonstrat

1. What is polyurethane coating and why is it used in medical devices? Polyurethane coatings provide flexibility, durability, and biocompatibility, making them ideal for catheters, stents, and implantable scaffolds. They offer excellent abrasion resistance and can be tailored for different durometers to meet specific clinical needs.  2. What are the main application methods for polyurethane coatings? Common techniques include dip coating  and spray coating . Dip coating immer

1. What is ePTFE and why is it important in medical devices? Expanded Polytetrafluoroethylene (ePTFE) is a biocompatible fluoropolymer with a microporous structure. It offers excellent chemical resistance, flexibility, and controlled porosity, making it ideal for vascular and neurovascular implants. Its ability to minimize thrombogenicity and allow tissue ingrowth while maintaining structural integrity is why it’s widely used in stent-grafts, heart valves, and endovascular co

In the world of advanced medical device engineering, membrane technology plays a crucial role in enabling precision, flexibility, and performance that meet the most demanding clinical and design requirements. 1. Design Freedom    Membrane technology offers complete design flexibility, enabling any size, shape, or style. This freedom allows engineers to tailor the membrane precisely to the device’s functional and anatomical requirements. 2. Control Functions    Using the Micr

In the rapidly evolving world of medical implants, every detail matters from adhesion strength to manufacturing efficiency. That’s exactly where advanced scaffold‑covering technologies make a meaningful difference. (1)  It begins with strong adhesion surface activation, which enhances chemical bonding by applying functional groups and verifying adhesion in every production lot, ensuring consistent and reliable performance. (2)  Selective sealing capability adds another laye

In catheter shaft design, manufacturing methodology directly defines device performance. Traditional telescopic reflow processes have long been used to assemble multi-layer shafts, but they introduce limitations in bonding quality, design flexibility, tolerances, and transition control. Microlayer technology fundamentally changes this paradigm by enabling a continuous, deposition-based approach that integrates structure, flexibility, and precision into a single process. Proc

In today's world of advanced medical technologies, precision is paramount, especially in the development of minimally invasive medical devices. The demand for microlayer tubes made from low durometer materials is on the rise, and they are quickly becoming a game-changer in the field. While extruded tubes have long been favored for applications requiring stiffness and high wall thickness, they present significant challenges when it comes to miniature sizes with ultra-thin wall